|
|
ICD-9-CM codes for EGID
Eosinophilic Esophagitis 530.13
Eosinophilic Gastritis 535.7
Eosinophilic Gastroenteritis and
Eosinophilic Enteritis 558.41
Eosinophilic Colitis 558.42
|
HOPE Research Grants
American Partnership for Eosinophilic Disorders (APFED) Request for Proposals
APFED is seeking Letters of Intent for research proposals leading to the development of novel less invasive methods of diagnosis and management of eosinophil associated gastrointestinal diseases. Letters must be received by September 30th, 2010. Selected investigators will be invited to submit a formal proposal by November 15th, 2010. One grant of $150,000 spanning 3 years will be awarded and announced by March 1st, 2011. Contact Kathleen Sable, APFED Director of Grants, at grants@apfed.org
More information
The American Partnership for Eosinophilic Disorders (APFED) Young Investigator Grant
Junior faculty $50,000 one time grant
Eligibility: US medical school faculty with aggregate appointments of less than 5 years to support funding of eosinophil related research projects.
Deadline: Midnight November 1st, 2010
Be a part of HOPE on the Horizon for Eosinophilic Disorders.
Click here for details and applications
APFED announces 2010 HOPE Grant Recipient Sophie Fillon
Congratulations to 2010 HOPE Junior Faculty Grant Recipient Sophie Fillon, PhD!
Dr. Fillon University of Colorado Denver School of Medicine is working on research to determine the role of the microbiome in children with eosinophilic esophagitis (EoE). Dr Fillon writes: “Since joining the Gastrointestinal Eosinophilic Diseases Program (GEDP) in Denver in July 2007, I have enjoyed the opportunity to begin to address this goal. I have developed local and national collaborations to increase the robustness of my proposal. One of the critical parts of my work in the GEDP has been the exposure to the patients with EGIDs. In this setting, I have attended a number of events that has allowed me to see the applications of basic research and the connection to the care of patients. In each of these settings, I have been impressed with great need for discovery in the field of EGIDs. During the course of my career, I plan to deepen my commitment to patients with EGIDs”
Dr. Fillon’s long-term goal is to become a leader in the field of EGIDS and to mentor a younger generation of students and post-doctoral fellows to enter into this nascent field. “This APFED HOPE award provides me with an outstanding opportunity to develop this line of research and would provide me with my first step in my junior faculty career.”
APFED announces the 2009 HOPE Grant Recipients
Antonella Cianferoni MD, PhD
Dr. Cianferoni is an Assistant Professor of Pediatrics at the University Of Pennsylvania School Of Medicine and the Children's Hospital of Philadelphia in the Division of Allergy and Immunology. Dr. Cianferoni’s research focus is identification of novel genes and biomarkers that will add to the understanding, treatment and management of eosinophilic gastrointestinal diseases.
Dr. Cianferoni writes: “I am in the process of establishing a research program aimed to the understanding of the basic pathogenetic mechanisms of eosinophilic gastroeneteropathies. This is a tremendous opportunity, as The Children’s Hospital of Philadelphia is one of the main centers in the US that treats patients with Eosinophilic Esophagitis and related diseases. There is a great need to expand understanding and to identify novel pathogenetic mechanisms of EE and to identify biomarkers that will lead to better diagnostic tools and treatments of this still elusive disease.”
Carine Blanchard PhD
Dr. Blanchard is a Postdoctoral fellow and research instructor at Cincinnati Children’s Hospital and Medical Center in the Division of Allergy and Immunology, focusing on the molecular pathogenesis of Eosinophilic Esophagitis and food allergy related disorders.
Dr Blanchard writes: “My research will focus on mechanisms that induce eosinophilic disease, with the goal of ameliorating the pain and distress of eosinophilic esophagitis. If we truly uncover a major role for Uroplakin 1B in EE diagnosis, then this would lead to further studies aimed at trying to understand the fundamental basis of the disease pathology and pathogenesis. Cincinnati Children’s Hospital Medical
Center (CCHMC) has a strong Center of Excellence in eosinophil biology and eosinophilic gastrointestinal disorders. My long-term goal is to become a leader in the field of human eosinophil associated gastrointestinal disorders, focusing on gene dysregulation and other mechanisms that lead to allergic gastrointestinal inflammation.”
APFED’s HOPE Grants are funded through private donations and fundraisers, including our annual walk. The HOPE grants foster career development of promising scientists who have a demonstrated a commitment to eosinophil associated diseases. Drs. Cianferoni and Blanchard will be invited to share their research at APFED’s annual conference this summer.
Congratulations to Seema Aceves MD, PhD for being the first recipient of the APFED HOPE Junior faculty awards for her research "Tissue remodeling in pediatric eosinophilic esophagitis: Influence on prognosis and response to corticosteroid therapy". Dr. Aceves is an adjunct assistant professor of pediatrics at the University of California San Diego.
APFED Announces Trainee Travel Grants for Professional meetings
For more information see our summary on Travel Grants. You can also download this information in PDF format.
Submit Travel Grant application Online.
Applicants must provide the following:
• Acceptance Letter for Presentation
• Copy of letter from Program Director confirming status
• Copy of accepted abstract
• Brief description of applicant’s interest in eosinophilic disorders
• A paragraph on short-term and long-term career goals and plans
• Projected expenses with specific expense information/receipts/bills
• Completed Contact Information Sheet
Download the Reimbursement Form to submit your expenses (following approval).
Please address all inquiries regarding research grants via email.
Congratulations to all APFED trainee grant recipients!
2006
Miguel Stein, MD
Cincinnati Children's Hospital Medical Center
“Anti-IL-5 (Mepolizumab) Therapy in Hypereosinophilic Syndromes and Eosinophilic Esophagitis: Cytokine Secretion and Decreased Peripheral Blood Eosinophilia”
Thuy Anh Le, MD
Feinberg School of Medicine
“Distinct Allergic Predisposition of Children and Adults with Eosinophilic Esophagitis”
Elizabeth A. Schaefer, M.D,
Riley Hospital for Children Indiana University School of
“ORAL PREDNISONE (P) IS NOT SUPERIOR TO TOPICAL FLUTICASONE (F) IN THE TREATMENT OF ALLERGIC EOSINOPHILIC ESOPHAGITIS (AEE)”
2008
Vincent Mukkada, MD
The Children's Hospital of Denver/University of Colorado Health Sciences Center
“EOSINOPHILS ENHANCE INTESTINAL EPITHELIAL BARRIER”
Samantha Woodruff, MD
University of Colorado Denver School of Medicine and The Children's Hospital in Denver, Colorado
“EoE lamina propria contains increased fibrosis”
2009
Guangju Luo
MD University of Cincinnati
“Coexistence of eosinophilic esophagitis (EE) and celiac disease (CD)”
Brad Shepherd M.D.
Vanderbilt University
“Eosinophilic Esophagitis: Dilate or Medicate?”
Joanne Masterson, PhD
University of Colorado Denver School of Medicine
“Eosinophilic ileitis and tissue remodeling in the SAMP1/SkuSic mouse strain”
Anup Patel, MD
Stanford University
“Eosinophils Can Induce T cell Activation in Eosinophilic Esophagitis”
Eitan Rubenstein, MD
University of California, San
“Anti-Siglee-F Antibody Reduces Eosinophilic Inflammation in a Mouse Model of Eosinophilic Esophagitis”
2010
Julie Caldwell, Ph. D
Cincinnati Children's Hospital Medical Center
“Microarray Analysis of Eosinophilic Gastritis Identifies a Strong Link with Cadherin-like 26 Overexpression”
Request Patient Education Materials (up to 10 Free to members)
To order bulk amounts of brochures visit our store.
Brochures
|
